MEDIANTECHNOLOGIES news, videos and press releases - Page 2
For more news please use our advanced search feature.
MEDIANTECHNOLOGIES - More news...
MEDIANTECHNOLOGIES - More news...
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2023
- Median Technologies to Host Two Webcasts and Provide a Company Update on February 2, 2023
- Median Technologies Announces 2022 Revenue of €23.8 Million, up 16%, and an Order Backlog of €60.8 Million
- Median Technologies: Half Year Liquidity Contract Statement
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31st, 2022
- Median Technologies: Financial Communications Schedule for the First Half of 2023
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2022
- Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Extraordinary General Meeting on December 9, 2022
- Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2022
- Median Technologies Announces Its 2022 Half-year Results and Revenues for the Third Quarter
- Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of September 30th, 2022
- Median Technologies Announces Formation of Clinical Advisory Board for iBiopsy® Lung Cancer Screening
- Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of August 31st, 2022
- Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 – 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy®
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31st, 2022
- Median Technologies: Financial Communication Schedule for the Second Half of 2022
- Half Year Median Technologies Liquidity Contract Statement Contracted with TP ICAP
- Median Technologies Communicates Its Business Indicators for the Second Quarter of 2022
- Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 – 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy®
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30th, 2022
- Median Technologies to host a live webcast and provide a company update on July 12, 2022
- Bryan Garnier & Co Initiates the Coverage of Median Technologies with a “Buy” Recommendation
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31st, 2022
- Median Technologies to Present an Abstract at the 2022 ASCO Annual Meeting, June 3 – 7, 2022, McCormick Place, Chicago, IL, USA
- Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy® Artificial Intelligence Technologies Into iCRO Imaging Services for Oncology Trials
- Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 14, 2022
- Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30th, 2022
- Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022
